Oyster Point Pharma, Inc.
SEC Filing List
OYST CIK: 0001720725
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SC 13G/A | Amendment to Schedule filed to report ac... | Rtw Investments, Lp | SCHULTE ROTH & ZABEL LLP /fa | 02/14/2023 | |
| SC 13G/A | Amendment to Schedule filed to report ac... | Point72 Asset Management, L.p. | WILLKIE FARR & GALLAGHER /fa | 02/14/2023 | |
| SC 13G/A | Amendment to Schedule filed to report ac... | Paradigm Biocapital Advisors Lp | Toppan Merrill/FA | 02/14/2023 | |
| SC 13D/A | Amendment to Schedule filed to report ac... | Versant Venture Capital Vi, L.p. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 01/13/2023 | |
| 8-K/A | Amendment to Current report filing | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 01/13/2023 | ||
| 15-12G | Notice of termination of registration of... | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 01/13/2023 | ||
| SC 13D/A | Amendment to Schedule filed to report ac... | New Enterprise Associates 14, L.p. | Go2 EDGAR SOLUTIONS LLC /fa | 01/09/2023 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 01/05/2023 | ||
| 4 | Statement of changes in beneficial owner... | DONNELLEY FINANCIAL SOLUTIONS 06/FA | 01/05/2023 | ||
| SC 13D/A | Amendment to Schedule filed to report ac... | Invopps Iv Us, L.p. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 01/05/2023 | |
| No record found. | |||||
| Load More | |||||